Olivia S. Long

590 total citations
7 papers, 434 citations indexed

About

Olivia S. Long is a scholar working on Aging, Molecular Biology and Cell Biology. According to data from OpenAlex, Olivia S. Long has authored 7 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Aging, 6 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Olivia S. Long's work include Genetics, Aging, and Longevity in Model Organisms (7 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Microbial Metabolic Engineering and Bioproduction (2 papers). Olivia S. Long is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (7 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Microbial Metabolic Engineering and Bioproduction (2 papers). Olivia S. Long collaborates with scholars based in United States and Canada. Olivia S. Long's co-authors include Gary A. Silverman, Cliff J. Luke, Stephen C. Pak, David H. Perlmutter, Joon Hyeok Kwak, Sager J. Gosai, Dale E. King, Kevin J. Kovatch, John S. Lazo and Donna B. Stolz and has published in prestigious journals such as Cell, PLoS ONE and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Olivia S. Long

7 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia S. Long United States 6 208 206 90 61 55 7 434
Li Wei Rachel Tay United States 6 92 0.4× 285 1.4× 50 0.6× 27 0.4× 86 1.6× 8 421
Eui Seung Lee United States 9 125 0.6× 316 1.5× 93 1.0× 83 1.4× 21 0.4× 12 535
R. Mako Saito United States 9 218 1.0× 359 1.7× 70 0.8× 24 0.4× 69 1.3× 10 553
Esther Marza France 12 51 0.2× 352 1.7× 191 2.1× 117 1.9× 71 1.3× 16 553
Vera Cherkasova United States 15 122 0.6× 851 4.1× 137 1.5× 41 0.7× 36 0.7× 19 998
En-Zhi Shen China 10 149 0.7× 520 2.5× 39 0.4× 46 0.8× 28 0.5× 19 618
Erwin Swinnen Belgium 14 123 0.6× 702 3.4× 130 1.4× 79 1.3× 95 1.7× 17 900
Alice Zuin Spain 9 104 0.5× 451 2.2× 88 1.0× 46 0.8× 24 0.4× 13 518
Daniel W. Neef United States 11 110 0.5× 751 3.6× 282 3.1× 59 1.0× 96 1.7× 11 880
Nazif Maqani United States 10 144 0.7× 302 1.5× 27 0.3× 68 1.1× 35 0.6× 11 414

Countries citing papers authored by Olivia S. Long

Since Specialization
Citations

This map shows the geographic impact of Olivia S. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia S. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia S. Long more than expected).

Fields of papers citing papers by Olivia S. Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia S. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia S. Long. The network helps show where Olivia S. Long may publish in the future.

Co-authorship network of co-authors of Olivia S. Long

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia S. Long. A scholar is included among the top collaborators of Olivia S. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia S. Long. Olivia S. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Long, Olivia S., Joon Hyeok Kwak, Cliff J. Luke, et al.. (2014). A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover. Human Molecular Genetics. 23(19). 5109–5122. 24 indexed citations
2.
O’Reilly, Linda P., Olivia S. Long, Murat Can Çobanoğlu, et al.. (2014). A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency. Human Molecular Genetics. 23(19). 5123–5132. 30 indexed citations
3.
Miedel, Mark T., Olivia S. Long, Stephen C. Pak, et al.. (2012). A Pro-Cathepsin L Mutant Is a Luminal Substrate for Endoplasmic-Reticulum-Associated Degradation in C. elegans. PLoS ONE. 7(7). e40145–e40145. 36 indexed citations
4.
Long, Olivia S., Sager J. Gosai, Joon Hyeok Kwak, et al.. (2011). Using Caenorhabditis elegans to Study Serpinopathies. Methods in enzymology on CD-ROM/Methods in enzymology. 499. 259–281. 2 indexed citations
5.
Gosai, Sager J., Joon Hyeok Kwak, Cliff J. Luke, et al.. (2010). Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z. PLoS ONE. 5(11). e15460–e15460. 135 indexed citations
6.
Silverman, Gary A., et al.. (2008). Modeling Molecular and Cellular Aspects of Human Disease Using the Nematode Caenorhabditis elegans. Pediatric Research. 65(1). 10–18. 75 indexed citations
7.
Luke, Cliff J., Stephen C. Pak, Yuko S. Askew, et al.. (2007). An Intracellular Serpin Regulates Necrosis by Inhibiting the Induction and Sequelae of Lysosomal Injury. Cell. 130(6). 1108–1119. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026